CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for ...
Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the ...
In the setting of Alzheimer’s and other neurodegenerative diseases, do T cells make things better, or worse? A simple answer just won’t do—it likely depends on the type of T cells, where they are in ...
Researchers from The University of Osaka find that only a small fraction of T cells may drive the robust anti-cancer response ...
MARCH 18, 2026, NEW YORK – The immune system’s killer T cells do a commendable job of detecting and destroying cancer cells. But the harsh environment at the heart of tumors often saps them of their ...
MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much ...
CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has revolutionized how physicians treat cancer, especially blood cancers. “These patients can be cured ...
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers. Yet, despite their ...
Active aldehydes drive T cell exhaustion in the tumor microenvironment This motivated a team of researchers from Kyoto University to investigate this conundrum. A key physiological role of FAO is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results